NIH spending nearly $470 million on ‘long-haul COVID’ study
Sep 16, 2021
The goal is to uncover why some people have prolonged symptoms or develop new or returning symptoms after recovering from COVID-19.
Pandemic likely to worsen financial woes for assisted living operators
By
Amy Novotney
Apr 10, 2020
Assisted living facilities have come under increased scrutiny during the COVID-19 pandemic. Challenges include deepening financial pressures, sicker residents, limited oversight and too few employees....
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.
$40 billion federal COVID-19 relief program includes funds for assisted living workforce development
By
Kimberly Bonvissuto
Jul 14, 2022
The Biden administration on Wednesday announced the investment of more than $40 billion in American Rescue Plan funds in workforce development programs, led by state and local governments and organizations,...
With evolving OSHA standards, senior living industry ‘not waiting on government action to run their...
By
Kimberly Bonvissuto
Dec 21, 2021
With guidance changing by the day, earlier recommendations of “be prepared to act” are echoing louder for assisted living providers. Although the Department of Labor’s Occupational Safety and Health...
Pfizer-BioNTech COVID-19 vaccine receives full FDA approval
Aug 23, 2021
The vaccine will now be marketed as Comirnaty and is fully approved for the prevention of COVID-19 in individuals 16 years and older.
24 state attorneys general threaten legal action over ‘disastrous and counterproductive’ vaccine...
By
Kathleen Steele Gaivin
Sep 20, 2021
President Joe Biden’s plan to require employers with 100 or more workers to mandate COVID-19 vaccination or frequent testing is meeting with opposition at the state level, with 24 Republican attorneys...
Risk for Guillain-Barré syndrome up after Ad.26.COV2.S vaccination
Apr 26, 2022
An adjusted rate ratio of 20.56 was found in a head-to-head comparison of the Johnson & Johnson vaccine and the Pfizer-BioNTech and Moderna COVID-19 vaccines.
Social isolation contributes to increased likelihood of dementia: study
By
Kimberly Bonvissuto
Jan 11, 2023
Social isolation is common among older adults in the United States — experienced by one in four of them — and increases the likelihood of developing dementia, according to the results of a new study.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.